APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Outlook and Growth Opportunities 2026

25 December 2025194 pages

Choose your research edition.

Industry ResearchHuman EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit market include Yuanma Gene, Shihe Medical, Xiamen Feishuo Biotechnology, Burning Rock, Qiuzhen Medical, Novogene, Jinqirui Biotechnology, BGI and Hangzhou Lianchuan Gene, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit market size, projected growth trends, production technologies, key applications, and end-use industries.

Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Segment by Company

Yuanma Gene

Shihe Medical

Xiamen Feishuo Biotechnology

Burning Rock

Qiuzhen Medical

Novogene

Jinqirui Biotechnology

BGI

Hangzhou Lianchuan Gene

TRUPCR

HLB PanaGene

AmoyDx

Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Segment by Type

Sequencing Method

Fluorescence PCR Method

Other

Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Segment by Application

Clinical

Scientific Research

Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit significant trends, drivers, influence factors in global and regions.

6. To analyze Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit industry.

Chapter 3: Detailed analysis of Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Industry Trends Table 2. Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Industry Drivers Table 3. Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Industry Opportunities and Challenges Table 4. Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Industry Restraints Table 5. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Share by Company (2021-2026) Table 7. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Volume Share by Company (2021-2026) Table 9. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Company Ranking, (2024-2026) & (USD Million) Table 11. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Key Company Manufacturing Base & Headquarters Table 12. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Company, Product Type & Application Table 13. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Sequencing Method Table 18. Significant Companies of Fluorescence PCR Method Table 19. Significant Companies of Other Table 20. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Volume Share by Type (2021-2026) Table 24. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Volume Share by Type (2027-2032) Table 25. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type (2021-2026) Table 29. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Clinical Table 31. Significant Companies of Scientific Research Table 32. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Volume Share by Application (2021-2026) Table 36. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Volume Share by Application (2027-2032) Table 37. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application (2021-2026) Table 41. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application (2027-2032) Table 42. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Region (2021-2026) & (K Units) Table 44. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Market Share by Region (2021-2026) Table 45. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Region (2027-2032) & (K Units) Table 46. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Market Share by Region (2027-2032) Table 47. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Region (2021-2026) Table 50. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Region (2027-2032) Table 52. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Country (2021-2026) & (K Units) Table 57. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Market Share by Country (2021-2026) Table 58. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Country (2027-2032) & (K Units) Table 59. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Market Share by Country (2027-2032) Table 60. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Market Share by Country (2021-2026) Table 62. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Market Share by Country (2027-2032) Table 64. Yuanma Gene Company Information Table 65. Yuanma Gene Business Overview Table 66. Yuanma Gene Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Yuanma Gene Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio Table 68. Yuanma Gene Recent Development Table 69. Shihe Medical Company Information Table 70. Shihe Medical Business Overview Table 71. Shihe Medical Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Shihe Medical Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio Table 73. Shihe Medical Recent Development Table 74. Xiamen Feishuo Biotechnology Company Information Table 75. Xiamen Feishuo Biotechnology Business Overview Table 76. Xiamen Feishuo Biotechnology Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Xiamen Feishuo Biotechnology Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio Table 78. Xiamen Feishuo Biotechnology Recent Development Table 79. Burning Rock Company Information Table 80. Burning Rock Business Overview Table 81. Burning Rock Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Burning Rock Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio Table 83. Burning Rock Recent Development Table 84. Qiuzhen Medical Company Information Table 85. Qiuzhen Medical Business Overview Table 86. Qiuzhen Medical Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Qiuzhen Medical Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio Table 88. Qiuzhen Medical Recent Development Table 89. Novogene Company Information Table 90. Novogene Business Overview Table 91. Novogene Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Novogene Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio Table 93. Novogene Recent Development Table 94. Jinqirui Biotechnology Company Information Table 95. Jinqirui Biotechnology Business Overview Table 96. Jinqirui Biotechnology Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Jinqirui Biotechnology Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio Table 98. Jinqirui Biotechnology Recent Development Table 99. BGI Company Information Table 100. BGI Business Overview Table 101. BGI Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. BGI Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio Table 103. BGI Recent Development Table 104. Hangzhou Lianchuan Gene Company Information Table 105. Hangzhou Lianchuan Gene Business Overview Table 106. Hangzhou Lianchuan Gene Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Hangzhou Lianchuan Gene Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio Table 108. Hangzhou Lianchuan Gene Recent Development Table 109. TRUPCR Company Information Table 110. TRUPCR Business Overview Table 111. TRUPCR Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. TRUPCR Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio Table 113. TRUPCR Recent Development Table 114. HLB PanaGene Company Information Table 115. HLB PanaGene Business Overview Table 116. HLB PanaGene Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. HLB PanaGene Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio Table 118. HLB PanaGene Recent Development Table 119. AmoyDx Company Information Table 120. AmoyDx Business Overview Table 121. AmoyDx Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. AmoyDx Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio Table 123. AmoyDx Recent Development Table 124. Key Raw Materials Table 125. Raw Materials Key Suppliers Table 126. Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Distributors List Table 127. Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Customers List Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Image Figure 2. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value (2021-2032) & (US$ Million) Figure 4. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales (2021-2032) & (K Units) Figure 5. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Sequencing Method Image Figure 10. Fluorescence PCR Method Image Figure 11. Other Image Figure 12. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Volume Share by Type (2021-2032) Figure 15. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type (2021-2032) Figure 18. Clinical Image Figure 19. Scientific Research Image Figure 20. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Volume Share by Application (2021-2032) Figure 23. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application (2021-2032) Figure 26. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value (2021-2032) & (US$ Million) Figure 31. North America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value (2021-2032) & (US$ Million) Figure 37. South America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Sequencing Method
  • Fluorescence PCR Method
  • Other
Applications
  • Clinical
  • Scientific Research
Companies covered
  • Yuanma Gene
  • Shihe Medical
  • Xiamen Feishuo Biotechnology
  • Burning Rock
  • Qiuzhen Medical
  • Novogene
  • Jinqirui Biotechnology
  • BGI
  • Hangzhou Lianchuan Gene
  • TRUPCR
  • HLB PanaGene
  • AmoyDx

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value (2021-2032)
  4. 1.2.2 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Volume (2021-2032)
  5. 1.2.3 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Dynamics
  1. 2.1 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Industry Trends
  2. 2.2 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Industry Drivers
  3. 2.3 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Industry Opportunities and Challenges
  4. 2.4 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Industry Restraints
3 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market by Company
  1. 3.1 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Company Revenue Ranking in 2025
  2. 3.2 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Company (2021-2026)
  3. 3.3 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Volume by Company (2021-2026)
  4. 3.4 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Average Price by Company (2021-2026)
  5. 3.5 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Company Ranking (2024-2026)
  6. 3.6 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Company Manufacturing Base and Headquarters
  7. 3.7 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Company Product Type and Application
  8. 3.8 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market by Type
  1. 4.1 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Type Introduction
  2. 4.1.1 Sequencing Method
  3. 4.1.2 Fluorescence PCR Method
  4. 4.1.3 Other
  5. 4.2 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Volume by Type
  6. 4.2.1 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value by Type
  10. 4.3.1 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value by Type (2021-2032)
  12. 4.3.3 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type (2021-2032)
5 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market by Application
  1. 5.1 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Application Introduction
  2. 5.1.1 Clinical
  3. 5.1.2 Scientific Research
  4. 5.2 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Volume by Application
  5. 5.2.1 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value by Application
  9. 5.3.1 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value by Application (2021-2032)
  11. 5.3.3 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application (2021-2032)
6 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Regional Sales and Value Analysis
  1. 6.1 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Region (2021-2032)
  3. 6.2.1 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Region: 2021-2026
  4. 6.2.2 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Region (2027-2032)
  5. 6.3 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value by Region (2021-2032)
  7. 6.4.1 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value by Region: 2021-2026
  8. 6.4.2 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value by Region (2027-2032)
  9. 6.5 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value (2021-2032)
  12. 6.6.2 North America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value (2021-2032)
  15. 6.7.2 Europe Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value (2021-2032)
  21. 6.9.2 South America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Country, 2025 VS 2032
7 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Country-level Sales and Value Analysis
  1. 7.1 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Country (2021-2032)
  4. 7.3.1 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Country (2021-2026)
  5. 7.3.2 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Country (2027-2032)
  6. 7.4 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value by Country (2021-2032)
  7. 7.4.1 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value by Country (2021-2026)
  8. 7.4.2 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Yuanma Gene
  2. 8.1.1 Yuanma Gene Company Information
  3. 8.1.2 Yuanma Gene Business Overview
  4. 8.1.3 Yuanma Gene Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Yuanma Gene Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio
  6. 8.1.5 Yuanma Gene Recent Developments
  7. 8.2 Shihe Medical
  8. 8.2.1 Shihe Medical Company Information
  9. 8.2.2 Shihe Medical Business Overview
  10. 8.2.3 Shihe Medical Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Shihe Medical Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio
  12. 8.2.5 Shihe Medical Recent Developments
  13. 8.3 Xiamen Feishuo Biotechnology
  14. 8.3.1 Xiamen Feishuo Biotechnology Company Information
  15. 8.3.2 Xiamen Feishuo Biotechnology Business Overview
  16. 8.3.3 Xiamen Feishuo Biotechnology Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Xiamen Feishuo Biotechnology Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio
  18. 8.3.5 Xiamen Feishuo Biotechnology Recent Developments
  19. 8.4 Burning Rock
  20. 8.4.1 Burning Rock Company Information
  21. 8.4.2 Burning Rock Business Overview
  22. 8.4.3 Burning Rock Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Burning Rock Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio
  24. 8.4.5 Burning Rock Recent Developments
  25. 8.5 Qiuzhen Medical
  26. 8.5.1 Qiuzhen Medical Company Information
  27. 8.5.2 Qiuzhen Medical Business Overview
  28. 8.5.3 Qiuzhen Medical Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Qiuzhen Medical Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio
  30. 8.5.5 Qiuzhen Medical Recent Developments
  31. 8.6 Novogene
  32. 8.6.1 Novogene Company Information
  33. 8.6.2 Novogene Business Overview
  34. 8.6.3 Novogene Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Novogene Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio
  36. 8.6.5 Novogene Recent Developments
  37. 8.7 Jinqirui Biotechnology
  38. 8.7.1 Jinqirui Biotechnology Company Information
  39. 8.7.2 Jinqirui Biotechnology Business Overview
  40. 8.7.3 Jinqirui Biotechnology Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Jinqirui Biotechnology Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio
  42. 8.7.5 Jinqirui Biotechnology Recent Developments
  43. 8.8 BGI
  44. 8.8.1 BGI Company Information
  45. 8.8.2 BGI Business Overview
  46. 8.8.3 BGI Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 BGI Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio
  48. 8.8.5 BGI Recent Developments
  49. 8.9 Hangzhou Lianchuan Gene
  50. 8.9.1 Hangzhou Lianchuan Gene Company Information
  51. 8.9.2 Hangzhou Lianchuan Gene Business Overview
  52. 8.9.3 Hangzhou Lianchuan Gene Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Hangzhou Lianchuan Gene Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio
  54. 8.9.5 Hangzhou Lianchuan Gene Recent Developments
  55. 8.10 TRUPCR
  56. 8.10.1 TRUPCR Company Information
  57. 8.10.2 TRUPCR Business Overview
  58. 8.10.3 TRUPCR Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 TRUPCR Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio
  60. 8.10.5 TRUPCR Recent Developments
  61. 8.11 HLB PanaGene
  62. 8.11.1 HLB PanaGene Company Information
  63. 8.11.2 HLB PanaGene Business Overview
  64. 8.11.3 HLB PanaGene Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 HLB PanaGene Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio
  66. 8.11.5 HLB PanaGene Recent Developments
  67. 8.12 AmoyDx
  68. 8.12.1 AmoyDx Company Information
  69. 8.12.2 AmoyDx Business Overview
  70. 8.12.3 AmoyDx Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 AmoyDx Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio
  72. 8.12.5 AmoyDx Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Value Chain Analysis
  2. 9.1.1 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Mode & Process
  6. 9.2 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Distributors
  9. 9.2.3 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst